TAMs are potent producers of CCL18, which can further enhance NF-κB signaling in NPC cells, heighten the release of VEGF and GM-CSF, and induce EMT, forming a forward-feeding loop to drive NPC metastasis [135]. The gene discussed is CSF2; the disease is nasopharyngeal carcinoma.